Cargando…

Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance

The identification of molecules that can reliably detect the presence of a tumor or predict its behavior is one of the biggest challenges of research in cancer biology. Biological fluids are intriguing mediums, containing many molecules that express the individual health status and, accordingly, may...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maramotti, Sally, Paci, Massimiliano, Manzotti, Gloria, Rapicetta, Cristian, Gugnoni, Mila, Galeone, Carla, Cesario, Alfredo, Lococo, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849047/ https://www.ncbi.nlm.nih.gov/pubmed/27104520 http://dx.doi.org/10.3390/ijms17040593

Ejemplares similares

Preliminary Evidence on the Diagnostic and Molecular Role of Circulating Soluble EGFR in Non-Small Cell Lung Cancer
por: Lococo, Filippo, et al.
Publicado: (2015)

Primary pulmonary MALT-lymphoma mimicking pulmonary infection: a case report and overview on the pertinent literature
por: Patricelli, Giulia, et al.
Publicado: (2017)

Soluble epidermal growth factor receptor (sEGFR) and carcinoembryonic antigen (CEA) concentration in patients with non-small cell lung cancer: correlation with survival after erlotinib and gefitinib treatment
por: Kappers, I, et al.
Publicado: (2010)

Asymptomatic air-embolism following percutaneous radiofrequency ablation of lung tumor: Rare or underestimated complication?
por: Rapicetta, Cristian, et al.
Publicado: (2015)

Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016)

HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019)

PUREAIR protocol: randomized controlled trial of intensive pulmonary rehabilitation versus standard care in patients undergoing surgical resection for lung cancer
por: Fugazzaro, Stefania, et al.
Publicado: (2017)

Is Adjuvant Chemotherapy Worthwhile After Radical Resection for Single Lung Metastasis From Colorectal Cancer? A Multicentric Analysis Evaluating the Risk of Recurrence
por: Rapicetta, Cristian, et al.
Publicado: (2019)

OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
por: Gugnoni, Mila, et al.
Publicado: (2022)

Cystic fibrohistiocytic tumor of the lung presenting as a solitary lesion
por: Paci, Massimiliano, et al.
Publicado: (2010)

Massive right hemothorax as the source of hemorrhagic shock after laparoscopic cholecystectomy - case report of a rare intraoperative complication
por: Cristian, Rapicetta, et al.
Publicado: (2011)

Correction: Massive right hemothorax as the source of hemorrhagic shock after laparoscopic cholecystectomy - case report of a rare intraoperative complication
por: Rapicetta, Cristian, et al.
Publicado: (2013)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

The Influence of COVID-19 on New Lung Cancer Diagnoses, by Stage and Treatment, in Northern Italy
por: Mangone, Lucia, et al.
Publicado: (2023)

Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer
por: Gugnoni, Mila, et al.
Publicado: (2019)

Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients
por: Bisagni, Alessandra, et al.
Publicado: (2018)

No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
por: Vitale, Emanuele, et al.
Publicado: (2021)

Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
por: Gugnoni, Mila, et al.
Publicado: (2023)

RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
por: Sancisi, Valentina, et al.
Publicado: (2017)

KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
por: Lorenzini, Eugenia, et al.
Publicado: (2022)

Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
por: Gandolfi, Greta, et al.
Publicado: (2017)

Chest wall tumors and prosthetic reconstruction: A comparative analysis on functional outcome
por: Leuzzi, Giovanni, et al.
Publicado: (2015)

Five Functional Aspects of the Epidermal Barrier
por: Lefèvre-Utile, Alain, et al.
Publicado: (2021)

Endobronchial Hamartoma Subtotally Occluding the Right Main Bronchus and Mimicking Bronchial Carcinoid Tumor
por: Lococo, Filippo, et al.
Publicado: (2016)

Rationale and clinical benefits of an intensive long-term pulmonary rehabilitation program after oesophagectomy: preliminary report
por: Lococo, Filippo, et al.
Publicado: (2012)

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
por: Peraldo-Neia, Caterina, et al.
Publicado: (2011)

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
por: Magkou, Christina, et al.
Publicado: (2008)

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
por: Vitale, Emanuele, et al.
Publicado: (2022)

MORPHOLOGICAL AND FUNCTIONAL ASPECTS OF AN INSECT EPIDERMAL GLAND
por: Stuart, A. M., et al.
Publicado: (1968)

Soluble EGFR, a hepatokine, and adipsin, an adipokine, are biomarkers correlated with distinct aspects of insulin resistance in type 2 diabetes subjects
por: Kyohara, Mayu, et al.
Publicado: (2020)

EGFR Soluble Isoforms and Their Transcripts Are Expressed in Meningiomas
por: Guillaudeau, Angélique, et al.
Publicado: (2012)

Prognostic Factors and Long-Term Survival in Locally Advanced NSCLC with Pathological Complete Response after Surgical Resection Following Neoadjuvant Therapy
por: Lococo, Filippo, et al.
Publicado: (2020)

Epidermal growth factor receptors (EGFR) in human ovarian cancer.
por: Owens, O. J., et al.
Publicado: (1991)

Development of an Epidermal Growth Factor Derivative with EGFR Blocking Activity
por: Panosa, Clara, et al.
Publicado: (2013)

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer
por: Berasain, Carmen, et al.
Publicado: (2011)

Epidermal to Mesenchymal Transition and Failure of EGFR-Targeted Therapy in Glioblastoma
por: Pala, Andrej, et al.
Publicado: (2012)

Nuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas
por: Pereira, Núbia Braga, et al.
Publicado: (2015)

Which Is the Best Treatment in Recurrent Thymoma? A Systematic Review and Meta-Analysis
por: Chiappetta, Marco, et al.
Publicado: (2021)

AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer - culprits for resistance to EGFR inhibitors?
por: Heideman, Marinus R, et al.
Publicado: (2013)

Dermoscopic aspect of verrucous epidermal nevi: new findings
por: ELMAS, Ömer Faruk, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1n6ob5b7tdgoqh718ipmds5u7b